NCT06872255

Brief Summary

Laparoscopic fundoplication represents the standard antireflux procedure, when conservative measures fail. However, any type of fundoplication may be accompanied by adverse events. Postfundoplication dysphagia (PFD) may hamper results of anti-reflux surgery. Endoscopic pneumatic dilation has been considered as the first line treatment option for persistent PFD. However, studies have not confirmed its effectiveness in this indication. Peroral endoscopic myotomy (POEM) became a standard treatment for the management of esophageal achalasia and moreover has also been assessed in a small cohort of patients with refractory PFD and some patients achieved significant treatment success. We plan to perform a prospective international cohort multicenter study assessing the efficacy of POEM in patients with persistent and severe PFD.

Trial Health

67
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
13mo left

Started Apr 2025

Typical duration for not_applicable

Geographic Reach
2 countries

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Apr 2025Jun 2027

First Submitted

Initial submission to the registry

February 10, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 12, 2025

Completed
20 days until next milestone

Study Start

First participant enrolled

April 1, 2025

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

March 12, 2025

Status Verified

February 1, 2025

Enrollment Period

2.2 years

First QC Date

February 10, 2025

Last Update Submit

March 6, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Efficacy and safety of POEM in patients with postfundoplication dysfagia

    The primary outcome will be proportion of patients with treatment success defined as Eckardt score ≤ 2 and its decrease by at least 1 point after POEM at 6 months

    6 months

Secondary Outcomes (11)

  • Eckardt score

    At baseline and after 3, 6 and 12 months

  • Mellow - Pinkas score

    At baseline and after 3, 6 and 12 months

  • PAGI-QOL score (Patient Assessment of Upper Gastrointestinal Disorders-Quality of Life)

    At baseline and after 3, 6 and 12 months

  • GERD-RHQL score (Gastroesophageal Reflux Disease Health-related Quality of Life)

    At baseline and after 3, 6 and 12 months

  • Integrated Relaxation Pressure (IRP)

    At baseline and after 6 months

  • +6 more secondary outcomes

Study Arms (1)

POEM arm

EXPERIMENTAL

Patients, who will undergo peroral endoscopic myotomy for postfundoplication dysphagia

Procedure: Per Oral Endoscopic Myotomy (POEM)

Interventions

All procedures will be performed by an experienced endoscopist, with a sufficient experience in "third space" endoscopy (at least 100 POEMs) under general anesthesia (internal preoperative examination is necessary) with a high-definition endoscope, fitted with a plastic distal attachment. Before the procedure, the patients will be administered intravenous antibiotics. Exclusively CO2 will be used for insufflation. POEM will be performed in a similar way as in patients with achalasia - the procedure consists of 4 steps: (1) mucosal incision and tunnel entry, (2) submucosal tunneling, (3) myotomy, and (4) closure of the mucosal entry with endoscopic clips or other closure devices. Perioperative protocol might differ according the usual way of performing POEM in a given center.

POEM arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients after laparoscopic fundoplication procedure by Nissen (total, 360°), Dor (anterior, 180°) or Toupet (posterior, 270°) for gastroesophageal reflux disease no later than 10 years before enrolment.
  • Refractory (\> 6 months) and severe dysphagia after fundoplication procedure defined as an Eckardt score ≥3 and Mellow - Pinkas score ≥2 at baseline.
  • X-ray (contrasted radiographic examination of the esophagus) characterized by both: a.) tapered narrowing of the distal esophagus and GEJ; b.) partial/total stagnation of the contrast solution above the GEJ
  • Endoluminal planimetry: EGJ-DI \< 3 mm2/mmHg (with 40ml)
  • Age above 18 years
  • Signed informed consent form

You may not qualify if:

  • No previous attempt with at least one prokinetic drug
  • Previous esophageal myotomy (open, laparoscopic or endoscopic)
  • Primary esophageal motility disorder (achalasia etc.)
  • Active erosive esophagitis
  • Active peptic ulcer disease
  • Esophageal stricture (peptic, malignant, other)
  • Partial or complete supradiaphragmatic migration of the wrap and/or stomach (Hinder Type III - IV), Large hiatal hernia more than 5 cm
  • Known eosinophilic esophagitis
  • Severe coagulopathy
  • Esophageal or gastric varices
  • Advanced liver cirrhosis (Child B or Child C)
  • Pregnancy or puerperium
  • Malignant or pre-malignant esophageal diseases (dysplasia): patients with a history of such disease after its cure are eligible for enrolment
  • Any other condition, which in the opinion of the investigator would interfere with study requirements
  • Known gastroparesis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

St. Anne's University Hospital Brno, Czech Republic

Brno, 60200, Czechia

Location

University Hospital Trnava

Trnava, 91701, Slovakia

Location

MeSH Terms

Conditions

Deglutition Disorders

Condition Hierarchy (Ancestors)

Esophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic Diseases

Central Study Contacts

Jan Martínek, prof., MD

CONTACT

Martin Vašátko, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Patients with refractory (\> 6 months) and severe dysphagia after fundoplication procedure defined as an Eckardt score ≥3 and Mellow - Pinkas score ≥2 at baseline, with proven obstruction of gastroesofageal junction (EGJOO)
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Gastroenterology and hepatology department

Study Record Dates

First Submitted

February 10, 2025

First Posted

March 12, 2025

Study Start

April 1, 2025

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

March 12, 2025

Record last verified: 2025-02

Locations